BioLife Solutions, Inc. Income (Loss) from Equity Method Investments
BioLife Solutions, Inc. (BLFS) reported Income (Loss) from Equity Method Investments of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2021-03-31
- BioLife Solutions, Inc. income (loss) from equity method investments for the quarter ending 2020-12-31 was $0.00.
- BioLife Solutions, Inc. income (loss) from equity method investments for the quarter ending 2020-09-30 was $0.00.
- BioLife Solutions, Inc. income (loss) from equity method investments for the quarter ending 2019-12-31 was $0.00.
- BioLife Solutions, Inc. income (loss) from equity method investments for the quarter ending 2019-09-30 was -$291.00K.
- BioLife Solutions, Inc. income (loss) from equity method investments for fiscal 2020 was $0.00.
- BioLife Solutions, Inc. income (loss) from equity method investments for fiscal 2019 was -$739.00K.
- BioLife Solutions, Inc. income (loss) from equity method investments for fiscal 2018 was -$672.00K.
- BioLife Solutions, Inc. income (loss) from equity method investments for fiscal 2017 was -$1.00M.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 3 month as first filed | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 6 month as first filed | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 9 month as first filed | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $0.00 10-K · filed 2021-03-31 | |||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | ||||||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 | |||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$291.00K derived: sum of 2 quarters · filed 2021-03-31 | -$508.00K derived: sum of 3 quarters · filed 2021-03-31 | -$739.00K 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | -$291.00K 10-Q · filed 2020-11-09 | -$508.00K derived: sum of 2 quarters · filed 2020-11-09 | -$739.00K 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | -$217.00K 10-Q · filed 2020-08-10 | -$448.00K 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | -$232.00K 10-Q · filed 2020-05-29 | |||||||
| 2019-03-30 | -$232.00K 10-K · filed 2020-05-15 | -$541.00K derived: sum of 2 quarters · filed 2020-05-15 | -$584.00K derived: sum of 3 quarters · filed 2020-05-15 | -$761.00K derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | -$309.00K derived: 10-K 12 month − 10-K 9 month · filed 2020-05-15 | -$352.00K derived: sum of 2 quarters · filed 2020-05-15 | -$529.00K derived: sum of 3 quarters · filed 2020-05-15 | -$672.00K 10-K · filed 2020-05-15 | ||||
| 2018-09-30 | -$43.00K 10-K · filed 2020-05-15 | -$42.69K 10-Q · filed 2018-11-08 | -$220.00K derived: sum of 2 quarters · filed 2020-05-15 | -$363.00K 10-K · filed 2020-05-15 | -$363.24K 10-Q · filed 2018-11-08 | |||
| 2018-06-30 | -$177.00K 10-K · filed 2020-05-15 | -$176.80K 10-Q · filed 2018-08-09 | -$321.00K 10-K · filed 2020-05-15 | -$320.55K 10-Q · filed 2018-08-09 | ||||
| 2018-03-31 | -$144.00K 10-K · filed 2020-05-15 | -$143.76K 10-Q · filed 2018-05-11 | ||||||
| 2018-03-30 | -$144.00K 10-K · filed 2020-05-15 | -$441.79K derived: sum of 2 quarters · filed 2020-05-15 | -$659.53K derived: sum of 3 quarters · filed 2020-05-15 | -$919.63K derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2017-12-31 | -$297.79K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$515.53K derived: sum of 2 quarters · filed 2019-03-15 | -$775.63K derived: sum of 3 quarters · filed 2019-03-15 | -$1.00M 10-K · filed 2019-03-15 | -$1.00M 10-K · filed 2018-03-09 | |||
| 2017-09-30 | -$217.74K 10-Q · filed 2018-11-08 | -$477.84K derived: sum of 2 quarters · filed 2018-11-08 | -$707.21K 10-Q · filed 2018-11-08 | -$707.21K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | -$260.11K 10-Q · filed 2018-08-09 | -$489.47K 10-Q · filed 2018-08-09 | -$489.47K derived: sum of 3 quarters · filed 2018-08-09 | -$489.47K derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | -$229.37K 10-Q · filed 2018-05-11 | -$229.37K derived: sum of 2 quarters · filed 2018-05-11 | -$229.37K derived: sum of 3 quarters · filed 2018-05-11 | -$229.37K derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-09 | $0.00 derived: sum of 3 quarters · filed 2018-03-09 | $0.00 10-K · filed 2018-03-09 | ||||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | |||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | ||||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |